Stay updated on Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T20:27:25.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Updates are limited to metadata changes, including the last update timestamps and a new revision (v3.4.2), with some dates moving from Estimated to Actual. There is no alteration to core study content, eligibility criteria, or treatment details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-12T02:28:48.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1. This appears to be a minor site maintenance update with no changes to study content or user workflow.
    Difference
    0.0%
    Check dated 2026-02-05T00:28:03.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added: Show glossary; Added footer metadata items including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed: 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' (To avoid being alerted by small changes, set an alert condition by clicking below).
    Difference
    0.2%
    Check dated 2026-01-28T21:25:15.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now shown in the page footer, replacing v3.3.3, a minor technical update with no effect on study details or navigation; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:59:01.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Locations section added with Ohio as a listed location. Ohio Locations and the HHS Vulnerability Disclosure footer were removed.
    Difference
    0.2%
    Check dated 2025-12-23T21:32:58.000Z thumbnail image

Stay in the know with updates to Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial page.